Life Science Sector Update August 2024

Nothing seems be happening lately in the market as we wait for Nvidia earnings. It’s the slowest week of the year, we are at the market top and most earnings reports are good. And FED Chairman Powell recently indicated a rate cut is coming in September. Smooth sailing  ahead so it seems although the next two months are seasonally weak and choppy. Maybe the recent 10% correction brought us calm because we have come all the way back. But there is still a feeling of unrest maybe because of the election year jitters.

Meanwhile the defensively oriented healthcare sector is catching up with the general market as the XLV is up 3.77% for the month and 14.10% YTD, compared to the S&P 500 up 3.14% for the month and 18.15% YTD. Over the past month sector performance has been broadening out with the financials, industrials and materials  outperforming technology (XLK) down 3.31% QTD. The QQQ is up 2.47% for one month and 15.94% YTD.

Life science stocks are having a good year particularly our Large Cap Biopharma picks as you can see from previous artlcles. All of our top picks have beat the QQQ by a huge %: ABBV,  LLY, REGN and VRTX (stay tuned for large cap biopharma review by next Monday).Recently we added Astra Zeneca (AZN) at a price of about $85 now at $87.42 up 29.8% YTD. GILD also looks good at $79 down 2.47% YTD.The major biotech ETFs are lagging  like the IBB is down 0.26% MTD and 8.85% YTD now near 2024 highs at $147.87. The small cap weighted more speculative XBI is down 0.46% MTD, and 1up 3.18% YTD just off  the 2024 high of $102.89. The MOmentum of the more speculative SMID caps has been good lately so we added the ARKG Genomic  Revolution ETF last week at about $26 and it is down 1.73% MTD and down 18.44% YTD. The  ARKG high for 2024 was $32.96.

Update 8/28 at the close: Top Biopharmas-Large Caps

2022 11/11/23 8/4 %YTD 5 Yr % P % YTD
8/28/24
ABBV 161.64 138.59 185.28 22.16 189.68 195.4 26.09
AMGN 333.99 15.96 78.39 329.49 14.4
AZN 68 63.17 81.81 21.47 79.57 87.36 29.71
BMY 71.05 50.61 48.77 -4.95 6.04 49.06 -4.39
GILD 85.39 75.92 76.77 -5.23 -18.2 78.56 -3.02
LLY 447.71 597.71 804.46 38 615.58 948.94 62.79
MRK 110.95 101.39 115.2 5.67 42.93 117.4 7.89
PFE 51.24 29.48 30.43 5.7 -15.6 28.75 0.14
REGN 725 798.94 1082.19 23.22 254.44 1199 36.55
VRTX 288.78 373.65 494.46 21.52 177.18 489.73 20.36

 

Last week we updated significant trades in our Life Science Picks and recently we happily noted CorMedix (CRMD) made a big move up 29.1% over 5 days and 64.10% YTD with no particular news driving the stock but a strong Business Update from the Company. CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. In this quarter the Company launched its DefenCath product in the outpatient setting with initial sales of $5.2M QTD as of  August 13.

In our last market update we tracked a number of trades from our Life Science Focus list and despite the volatility the performance has been good. This speculative list of trades has been screened for balance sheet, analyst coverage and unique technology. We are developing an algorithm to track momentum and financial performance over a quarterly period. But how can one follow so many stocks? Like Tempus AI (TEM) which has soared from $41 to $71.44 in one month and is now at the $65 level?

NOTE: This is not a “buy and hold” list but a guide for active traders. DATA as of 8/17/24.

Rayno Life Science Trades-Small and MidCap (SMID)

P 1/20/23 Initial 2/4/23 12/24/23 4/8/24 8/17/24
Company Ticker $ P YTD % YTD %YTD %MTD Rate cash MktCAP
P P % P Trade $M $-ooo-
Acumen Therap ABOS 5.29 3.57 -33.89 3.17 -17.45 2.57 -33.07 -18.4 H 281 154
Adaptive BiioTech ADPT 4.11 5 2.6 -46.94 4.83 -1.43 8.54 H,$ 291 712.3
Avidity Sciences RNA new 7/1/24 25 44.98 397 -3.64 185+ 5,270
Catalyst Pharma CPRX 16.1 16.58 -10.86 14.89 11.42 19.87 18.2 16.9 H 137+ 2,360
Caribou Biosci CRBU 6.29 6.17 -0.175 3.71 -35.25 2.09 -63.53 -23.44 H,$ 311.8 188.86
CorMedix CRMD 3.9 5.31 41.22 4.81 27.83 -3.8 H,$ 45.6 268.7
Crenetics CRNX 42.12 18.38 51.62 45 -6.11 500 4,130
CRSPR Therap CRSP 49.61 -25 55.27 63.67 56.63 53.91 -13.88 47.85 -23.56 -23.75 H 2,000 4,080
Cryoport CYRX 21.75 -42.34 25.24 16.09 -7.26 16.38 5.75 9.01 -41.83 3.92 H,L 700? 445
Cytokinetics CYTK 31 65.34 -21.74 56.5 -22.33 -0.46 1,400 6.,650
Denali DNLI 22 19.21 -9 23.02 7.27 -3.84 1350 3,300
Exelixis EXEL 22.25 23.75 -1.21 26.35 9.84 15.77 H 262? 7,520
Evolent Health EVH 30.83 13.74 31.96 32.08 14.25 27.65 -16.29 27.38 -17.11 26.06 S,L *37 wc 3,180
Geron GERN 3.19 9.24 3.22 2.29 -5.37 3.79 79.62 4.5 113.3 -9.82 S,H,$ *269 2,710
Humacyte HUMA new 8/1/24 8.25 6.48 128.17 -26.28 *80 773
Intelllia NTLA 25.5 22.63 (25.78 -17.26 H 130 2,380
Immatics IMTX 9.3 9.9 13.66 10 -4.94 11.51 9.31 -8.29 H 569 1,180
Natera NTRA 60 91.66 46.33 123.98 100.23 22.57 S,$ 796.8 15,330
Pacific Biosci PACB 11.29 55.68 11.58 8.59 5 1.47 -85 1.56 (83.790 -10.34 H,L 99 425,000
Novavax NVAX 3.67 12.96 170 921.17) S,H,$ 487.2 2,017,000
Recursion Pharm RXRX 10.75 8.12 -17.65 6.74 -31.64 -22.63 S,$ 483 1,900
Rezolute RZLT new 7/8/24 4.25 4.24 327 -11.13 S $ 80 234
Roivant ROIV 11.4 11.03 -1.78 11.19 -0.36 -3.62 5,695 8,280
Supernus SUPN 40.3 12.3 41.61 29.23 -18.05 30.07 3.9 34.55 19.38 19.38 H 350 1,900
Tempest AI TEM new 7/10/24 50.88 26.41 24.89 H S$ 479 7,850
Twist Biosci TWST 18 3.76 34.03 31.54 -14.53 43.56 18.18 -25.74 S,H,$ 289 2,555
10x Genomics TXG 47.84 56.58 55.27 27.59 -50.79 21.75 -61.13 8.75 S,$ 379.8 2,620
Vericel VCEL 31 34.75 31.93 46.05 29.32 46.28 29.96 -11.37 H 102.5 2,270
Veracyte VCYT 24.89 39.43 26.67 28.27 19.13 19.31 -29.81 32.85 19.41 28.52 H,S$ 216 2,520
SPDR Biotech XBI 86.99 14.75 90.39 87.62 5.57 83.49 -6.51 97.77 9.5 -4.01 H,S,$
iShares BIO IBB 133.77 -1.89 132.51 -2.48 144.85 6.62 -2.08
HealthcareSPDR XLV 135.02 143.22 5.02 152.87 12.09 2.01
wildcard
ArkGenomics ARKG 35.28 32.81 16.22 23.18 -29.35 26 -20.76 -5.14 h
T.RowePrice PRHSX 86.84 -3.32 92.49 5.22 99.68 13.4 H,$

Pin It on Pinterest